The selling appears tied to liquidity events following a large equity grant, not necessarily bearish sentiment. Monitor for continued selling beyond tax-related or diversification motives. The grants may increase future share-based compensation expenses.
Price Chart
Executive Summary
Multiple C-suite executives at Surgery Partners sold shares in the open market on March 6, 2026, following a prior-day grant of over 284,000 shares to the same executives. The total open-market sales amounted to $723,452, while the grants totaled approximately $3.9 million in value.
Key Financial Metrics
Key Facts
- CEO Jason Evans sold $158,061 in shares on March 6, following a grant of 141,743 shares worth $1.99 million the prior day.
- CFO David Doherty sold $201,704 in shares and was granted 56,697 shares worth $799,995 on March 5.
- All five named C-suite officers sold shares totaling $723,452 on March 6 at prices between $13.60 and $13.84.
- The same executives received stock grants on March 5 totaling $3.89 million in value.
- Open-market sales represent 0.04% of the company's $1.7B market cap — modest in scale.
Financial Impact
$723,452 in net open-market selling by insiders; offset by $3.89 million in non-cash grants the prior day
Risk Factors
- Perception of insider selling could pressure near-term sentiment despite likely routine post-grant selling.
- If sales continue beyond this cluster, it may signal deteriorating confidence.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CONTEXT: Insider Cluster Data (10 trades, 7d window) | cluster-SGRY-1773099219684 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 26, 2026 today | DEFA14A | $23.32 | awaiting T+5 | — | $23.19 (−0.54%) |
Oct 26, 2026 1d ago | SC 13D/A | $19.47 | awaiting T+5 | — | $23.19 (+19.13%) |
Oct 26, 2026 1d ago | DEFA14A | $19.47 | awaiting T+5 | — | $23.19 (+19.13%) |
Oct 26, 2026 1d ago | 8-K | $19.47 | awaiting T+5 | — | $23.19 (+19.13%) |
Oct 13, 2026 13d ago | SC 13G | $14.83 $15.40 | ▲ +3.84% | ▲ +3.39% | $23.19 (+56.41%) |
Sep 17, 2026 5w ago | 8-K | $13.35 $14.20 | ▲ +6.37% | ▲ +5.77% | $23.19 (+73.75%) |
Sep 17, 2026 5w ago | Press Release | $13.35 $14.20 | ▲ +6.37% | ▲ +5.52% | $23.19 (+73.75%) |
Aug 20, 2026 9w ago | Insider Buy | $14.52 $13.69 | ▼ −5.72% | ▼ −6.19% | $23.19 (+59.75%) |
Aug 10, 2026 11w ago | 8-K | $15.95 $14.36 | ▼ −9.97% | ▼ −9.92% | $23.19 (+45.42%) |
Aug 10, 2026 11w ago | Press Release | $15.95 $14.36 | ▼ −9.97% | ▼ −9.92% | $23.19 (+45.42%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers